Heart failure & cardiomyopathies

Albuminuria is Associated with Worse Outcomes in Non-Diabetics Hospitalized with Acute Heart Failure

ESC Heart FailPublished Secondary analysis of the Renal Optimization Strategies Evaluation-Acute Heart Failure (ROSE-AHF) randomised trial

Authors' conclusion

Albuminuria is largely not associated with the risk of death, cardiovascular death, or HF hospitalization in AHF, except admission UACR is associated with the risk of death in non-diabetics.

Study context

Population
Patients hospitalised with acute heart failure (HF) in ROSE-AHFbaseline urinary albumin-to-creatinine ratio (UACR)
Participants
339 patients
Comparison
Baseline, Day 7 and change in UACR
Primary endpoint
All-cause mortality; composite of first HF hospitalisation or CV mortality
Follow-up
6 months (mortality); 2 months (composite)

Primary result

As reported in the abstract

Deaths

65

HF hospitalisations or CV deaths

82

Further findings

OutcomeHR (95% CI)P value
All-cause mortality by baseline UACR, non-diabetics (subgroup)Not associated in diabetics2.58 (1.00–6.66)P = 0.050
  • All-cause mortality by baseline UACR, non-diabetics (subgroup): interaction by diabetes status P = 0.022

Day 7 UACR and change in UACR

Neither Day 7 UACR nor change in UACR associated with outcomes

Original publication

Albuminuria is Associated with Worse Outcomes in Non-Diabetics Hospitalized with Acute Heart Failure. ESC Heart Fail. Published 12 November 2025. doi:10.1002/ehf2.70006

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.